Skip to content

Clinical trials

Phase 1 Lymphoproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 1 Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20044
20052
20073
20084
20112
20121
20131
20141
20162
20171
20181
20191
20202
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Active, not recruiting4
Recruiting4
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine6
Seagen Inc.4
Jonsson Comprehensive Cancer Center2
National Institute of Allergy and Infectious Diseases (NIAID)2
UNC Lineberger Comprehensive Cancer Center2
AVEO Pharmaceuticals, Inc.1
Celularity Incorporated1
Children's Oncology Group1
DEKK-TEC, Inc.1
Kelonia Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders35
Lymphoma15
Lymphoma, Non-Hodgkin14
Hodgkin Disease11
Immunoproliferative Disorders11
Hematologic Diseases8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Burkitt Lymphoma7
Lymphatic Diseases7
Lymphoma, Large B-Cell, Diffuse7

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.